tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Immutep Ltd Highlights Immune System Innovations at Healthcare Conference
Company AnnouncementsImmutep Ltd Highlights Immune System Innovations at Healthcare Conference
7d ago
Immutep announces EFTISARC-NEO Phase II trial met primary endpoint
PremiumThe Fly
Immutep announces EFTISARC-NEO Phase II trial met primary endpoint
13d ago
IMMP
Immutep’s Efti Combination Therapy Achieves Success in Phase II Soft Tissue Sarcoma Trial
PremiumCompany Announcements
Immutep’s Efti Combination Therapy Achieves Success in Phase II Soft Tissue Sarcoma Trial
14d ago
Immutep’s Promising Phase 1 INSIGHT-003 Results Drive Buy Rating
PremiumRatings
Immutep’s Promising Phase 1 INSIGHT-003 Results Drive Buy Rating
21d ago
IMMP
Immutep announces response rates from INSIGHT-003 trial
PremiumThe Fly
Immutep announces response rates from INSIGHT-003 trial
25d ago
IMMP
Immutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
PremiumCompany AnnouncementsImmutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
25d ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
MRK
ATHE
Immutep’s Promising Phase 2b Results and Strong Financial Position Justify Buy Rating
Premium
Ratings
Immutep’s Promising Phase 2b Results and Strong Financial Position Justify Buy Rating
1M ago
IMMP
Immutep announces results from Phase IIb trial of TACTI-003
PremiumThe Fly
Immutep announces results from Phase IIb trial of TACTI-003
1M ago
MRK
IMMP
Immutep’s Efti Shows Promising Results in Head and Neck Cancer Trial
PremiumCompany Announcements
Immutep’s Efti Shows Promising Results in Head and Neck Cancer Trial
1M ago
Immutep reports Q3 cash receipts from customers A$12,000
PremiumThe Fly
Immutep reports Q3 cash receipts from customers A$12,000
1M ago
IMMP
Immutep Advances Cancer Trials with Promising Developments
PremiumCompany Announcements
Immutep Advances Cancer Trials with Promising Developments
1M ago
Immutep Advances in NSCLC Treatment with TACTI-004 Trial
PremiumCompany AnnouncementsImmutep Advances in NSCLC Treatment with TACTI-004 Trial
2M ago
Immutep Director Increases Stake Through Performance Rights Exercise
Premium
Company Announcements
Immutep Director Increases Stake Through Performance Rights Exercise
2M ago
Immutep Ltd Director Increases Shareholding Through Performance Rights Conversion
Premium
Company Announcements
Immutep Ltd Director Increases Shareholding Through Performance Rights Conversion
2M ago
Immutep Ltd Issues 4.8 Million New Securities on ASX
PremiumCompany Announcements
Immutep Ltd Issues 4.8 Million New Securities on ASX
2M ago
Immutep to Engage in Key Investor Conferences
PremiumCompany Announcements
Immutep to Engage in Key Investor Conferences
2M ago
Immutep’s Promising Clinical Developments and Strategic Collaborations Earn a Buy Rating
PremiumRatings
Immutep’s Promising Clinical Developments and Strategic Collaborations Earn a Buy Rating
2M ago
IMMP
Immutep announces first patient dosed in TACTI-004 Phase III trial
PremiumThe Fly
Immutep announces first patient dosed in TACTI-004 Phase III trial
3M ago
IMMP
Immutep Doses First Patient in Pivotal Phase III Lung Cancer Trial
PremiumCompany AnnouncementsImmutep Doses First Patient in Pivotal Phase III Lung Cancer Trial
3M ago
Immutep announces poster presentation for the TACTI-004 Phase III trial
Premium
The Fly
Immutep announces poster presentation for the TACTI-004 Phase III trial
3M ago
MRK
IMMP
Immutep to Present Pivotal Lung Cancer Trial at ELCC 2025
Premium
Company Announcements
Immutep to Present Pivotal Lung Cancer Trial at ELCC 2025
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >